Cincinnati Fertility - Institute for Reproductive Health - Cincinnati Ohio

Site Topics:

Home Cancer Risks

 Home  Links  Our Staff  Directions  Contact  Baby Bash



OVULATION DRUGS
Ovulation inducing agents are used in two different ways. First they are used for patients with irregular cycles to normalize ovulation. Secondly, they are used for normally ovulating women as an adjunct to intrauterine insemination. This is because insemination in the natural cycle has poor pregnancy rates.  There are two categories of ovulation drugs:  oral and injectable.  The oral medications are simple to take, inexpensive and have modest results.  The injectable drugs are more complex to administer but give far superior results.

Clomid and Serophene (oral medications):

The first line therapy are oral drugs such as Clomid or Serophene. These are identical drugs made by two different companies. They are both oral mild medications with modest results. These drugs work by stimulating the release of FSH and LH, which are the crucial hormones that stimulate egg production. The total pregnancy rate with these agents is 35 - 40% after 4 - 6 cycles of use. It is important to know that the lowest effective dose is best. Also most individuals will get pregnant with lower doses within the first few months of use. Therapy beyond 6 cycles is not useful in most cases. While the drug is administered, response can most accurately judged with ultrasound or progesterone levels. The reason some individuals will not get pregnant with this medication is that it thickens the cervical mucus and thins the lining of the uterus. Approximately 90% of all births are single with this medication. One such example is the young lady who appears below:

The multiple pregnancy rate with this medication should be no more than 7-10%. Most multiples seen here will be twins. Side effects include hot flushes and mood disturbance.

Injectable Drugs such as Pergonal:

Frequently, first line therapy is ineffective. We must then turn to the injectable ovulation inducing agents. These agents are in almost all cases functionally equal.

They can be divided into two groups:

  1. Older compounds that contain follicle stimulating hormone (FSH) and luteinizing hormone (LH). These compounds include: Repronex, Pergonal, and Humegon.
  2. Newer drugs that contain pure FSH: Follistim, Gonal F and Bravelle.

There has been a great deal of debate over whether FSH only is needed or FSH and LH. It appears that for most cases, FSH is probably enough. Each case is best managed individually. These agents share some common points. They are all expensive. One month's treatment can run $500-$1,000 in drug cost. They are also all injectable.   Typically, 7 - 10 days of shots are required per month. The newer agents (Gonal F and Follistim) are given with the smallest needles (subcutaneously). They are all prone to multiples. The incidence of multiples is approximately 15-20%. Most multiples contrary to popular belief are twins as pictured below. The incidence of triplets is 3-5%.

These agents are highly effective and will give cumulative pregnancy rates of roughly 50%. Side effects include various degrees of ovarian enlargement which causes the patient to feel " crampy or bloated". Close monitoring will improve results and possibly reduce the number of multiples seen. During treatment, blood work and ultrasounds are used to monitor response. Typically no more than 3 or 4 visits are required per month. When the follicles are judged to be mature, hCG is given to trigger ovulation at a precise time. Ovulation usually occurs 36-40 hours after hCG. In some cases, insemination will be performed around the time of ovulation. Injectable drugs are often effective when oral medications have failed. This is because they often produce better quality eggs and the lining of the uterus is more receptive to the embryo. It is important to know that the goal of injectable drugs is quality not quantity of egg production.

The Role of Artificial (intrauterine) Insemination

One common question that arises is whether insemination is desirable or necessary when ovulation drugs are used.  If we are treating a pure ovulation problem and the sperm count is normal, it may be purely optional.  If however we have a patient who is ovulating already and we are using ovulation drugs as part of a combined protocol of ovulation and intrauterine insemination, it is a required part of the treatment. 


For more information on each individual agent, please go to the patient education section.

Useful web sites for drug information are: http://www.seronousa.com and http://www.ferringusa.com.  For some fascinating information about ovarian production of eggs, please follow the following link:  http://www.seronocycle.com


©2002 Institute for Reproductive Health. All rights reserved.
3805 Edward Rd., Suite 450, Cincinnati, Ohio 45209